Codes / ICD10CM / E71.53

E71.53 Other group 2 peroxisomal disorders

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other group 2 peroxisomal disorders

Summary

Other group 2 peroxisomal disorders are a subset of genetic conditions affecting peroxisomes, cellular organelles essential for breaking down fatty acids, producing bile acids, and detoxifying harmful substances. These disorders disrupt metabolic processes, leading to the accumulation of toxic compounds or deficiency of essential metabolites, which can cause a range of metabolic and neurological problems.

Causes

Other group 2 peroxisomal disorders are caused by mutations in genes responsible for peroxisome function. These mutations impair the organelle's ability to perform its metabolic roles, resulting in the buildup of substances like very long-chain fatty acids or the deficiency of plasmalogens, which are vital for brain and lung function.

Risk Factors

  • Family history of peroxisomal disorders due to autosomal recessive inheritance.
  • Consanguineous relationships (parents who are closely related).

Symptoms

  • Developmental delays or regression.
  • Muscle weakness or hypotonia.
  • Seizures or abnormal eye movements.
  • Liver dysfunction or enlarged liver.
  • Abnormal facial features in some subtypes.

Diagnosis

Diagnosis involves biochemical testing to measure levels of very long-chain fatty acids, plasmalogens, or other peroxisomal metabolites in blood or urine. Genetic testing may confirm specific mutations, and imaging or clinical evaluation may assess organ involvement.

Treatment Options

Treatment focuses on managing symptoms and complications, such as dietary modifications to reduce fatty acid buildup, medications to address seizures or liver issues, and supportive therapies for developmental delays. Specific treatments depend on the subtype and severity.

Prognosis and Follow-Up

Prognosis varies by subtype and severity, with some individuals experiencing progressive neurological decline while others have milder symptoms. Regular follow-up with metabolic specialists, neurologists, and other healthcare providers is essential to monitor organ function and adjust care as needed.

Complications

Complications may include progressive neurological damage, liver failure, respiratory issues, and vision or hearing loss. Early intervention can help mitigate some risks, but outcomes depend on the specific disorder and timely management.

Lifestyle & Prevention

While genetic, lifestyle support focuses on managing symptoms: maintaining a balanced diet, adhering to prescribed therapies, and avoiding substances that may exacerbate metabolic issues. Genetic counseling is recommended for families with a history of peroxisomal disorders.

When to Seek Professional Help

Seek medical attention if symptoms like developmental delays, seizures, or unexplained liver issues appear, especially in infants or children. Prompt evaluation is critical for early diagnosis and intervention.

Tips for Medical Coders

Document the specific subtype of peroxisomal disorder when available, as coding requires specificity. Ensure clinical documentation supports the diagnosis, including relevant test results or specialist evaluations, to justify the use of E71.53.

Book a walkthrough

E71.53 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.